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NF-B plays an important role in the regulation 
of diverse biological processes such as develop-
ment, immune and inflammatory responses, and 
apoptosis (Baldwin, 1996; Gilmore, 2006; Ghosh 
and Hayden, 2008). Through its ubiquitous ap-
pearance, NF-B is involved in regulation of a 
wide range of genes, such as genes encoding cyto-
kines, adhesion molecules, cytokine receptors,   
immunoregulatory molecules, and antiapop-
totic proteins. In mammals, the NF-B tran-
scription factor family includes five members: 
p50/NF-B1, p52/NF-B2, RelA/p65, c-Rel, 
and RelB (Ghosh and Karin, 2002; Ghosh and 
Hayden, 2008). These polypeptide subunits form 
homo-  and  heterodimers  that  are  sequestered 
through stable association with inhibitor of B 
(IB) proteins in the cytoplasm of resting cells. 
Activators of the NF-B pathway, such as cyto-
kines, growth factors, and bacterial and viral 
products, strongly enhance the activity of the IB 
kinase complex (IKK). IKK phosphorylates the 
IB inhibitor proteins, leading to their rapid 
proteasomal degradation (Karin and Ben-Neriah, 
2000; Ghosh and Hayden, 2008). After degrada-
tion of IB, NF-B dimers are able to enter 
the nucleus, bind specifically to DNA, and 
modulate transcription of various target genes.
Because the initial discovery of the IB pro-
teins as the cytoplasmic inhibitors of NF-B, 
considerable effort has been given to understand 
regulation  and  modes  of  action  (Baeuerle  and 
Baltimore, 1988). IB and IB are the major 
signal-responsive isoforms within the IB family 
that also includes IB, IB, p100, p105, Bcl-3, 
and the newly described IB (Yamamoto et al., 
2004; Hoffmann and Baltimore, 2006). Although 
IB and IB show many common struc-
tural features, they exhibit functional differences 
(Thompson et al., 1995; Tran et al., 1997). IB is 
rapidly degraded upon stimulation, followed by 
immediate NF-B–dependent resynthesis. Newly 
synthesized IB enters the nucleus and removes 
NF-B  complexes  from  the  DNA  to  export 
them back to the cytoplasm (Sun et al., 1993; 
Klement et al., 1996; Hoffmann et al., 2002). 
In contrast, IB is degraded much more slowly, 
and its resynthesis is not regulated by NF-B. 
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Inhibitor of B (IB)  (IB) represents one of the major primary regulators of NF-B in 
mammals. In contrast to the defined regulatory interplay between NF-B and IB, much 
less is known about the biological function of IB. To elucidate the physiological role of 
IB in NF-B signaling in vivo, we generated IB-deficient mice. These animals proved 
to be highly refractory to LPS-induced lethality, accompanied by a strong reduction in 
sepsis-associated cytokine production. In response to LPS, IB is recruited to the IL-1 
promoter forming a complex with the NF-B subunits RelA/c-Rel required for IL-1  
transcription. Further transcriptome analysis of LPS-stimulated wild-type and IB- 
deficient BM-derived macrophages revealed several other genes with known regulatory 
functions in innate immunity arguing that a subset of NF-B target genes is under control 
of IB. Collectively, these findings provide an essential proinflammatory role for IB  
in vivo, and establish a critical function for IB as a transcriptional coactivator under  
inflammatory conditions.
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IB/ mice are highly resistant to LPS-induced  
septic shock
Previous studies demonstrated that LPS stimulation leads to 
IB degradation and persistent NF-B activity. To elucidate 
the role of IB during endotoxic shock, we analyzed the 
LPS responsiveness in IB/ mice (Thompson et al., 1995). 
Mice were intraperitoneally injected with a high dose of LPS 
(30 mg/kg), and survival was monitored (Fig. 2). IB/ 
mice demonstrate a remarkable resistance to the lethal effect 
of LPS (log-rank test IB/ versus WT, P < 0.0001) in 
contrast to WT animals that showed a 100% lethality within 
36 h after LPS injection. Although surviving IB+/ and 
IB/ mice showed signs of LPS-induced shock in the first 
hours, they completely recovered after 72 h, arguing for a sig-
nificant  protection  against  LPS-induced  septic  shock. The 
phenotype of the heterozygous mice suggests that both IB 
alleles are required for the full LPS response in vivo.
Deficiency of IB reduces the biosynthesis  
of the proinflammatory cytokines TNF, IL-1, and IL-6
LPS induces rapid production of inflammatory cytokines 
in vivo, leading to multiorgan failure of the host (Morrison 
and Ryan, 1987). To determine whether increased resis-
tance to endotoxic shock in IB/ mice was caused by 
decreased proinflammatory cytokines, we measured serum 
concentration of inflammatory cytokines TNF, IL-1, and 
IL-6  after  LPS  challenge. As  expected,  the  serum  levels   
of these cytokines were significantly increased upon LPS 
treatment in WT mice (Fig. 3 A). In contrast, only a moder-
ate increase of the serum concentrations of TNF, IL-1, 
and  IL-6  was  observed  in  IB/  mice.  Furthermore, 
mRNA levels of TNF, IL-1, and IL-6 in the liver after LPS 
injection  remained  significantly  lower  in  IB/  mice 
(Fig. 3 B). These data suggest that IB is essential for in 
vivo production of inflammatory cytokines during LPS-
induced septic shock.
IB deficiency modify IL-1 cytokine production  
in LPS-stimulated BMDMs
As macrophages represent the major source of inflammatory 
cytokine production during sepsis, we analyzed cytokine ex-
pression in WT and IB/ BMDMs. In contrast to WT 
BMDMs that showed increased TNF, IL-6, and IL-1 mRNA 
expression and protein secretion upon LPS stimulation, 
endotoxin treatment led to impaired IL-1 mRNA induc-
tion, pro–IL-1 expression, and IL-1 secretion in IB/ 
BMDMs (Fig. 4, A and B). Although no significant changes 
in either TNF mRNA induction or secretion were observed 
after LPS treatment, IL-6 secretion was affected only at later 
time points in IB/ BMDMs (Fig. 4 A), suggesting spe-
cific regulation of IL-1 transcription by IB in BMDMs. 
In addition to IL-1, we observed in transcriptome profiles of 
LPS-stimulated WT and IB/ BMDMs that several other 
genes that are known to be important for the regulation of 
innate  immunity  are  LPS  induced  in  an  IB-dependent 
manner (Table S1).
Depending on the cell type and stimulus, IB undergoes 
persistent degradation, contributing to constitutive NF-B 
activation (Thompson et al., 1995; Bourke et al., 2000). Fur-
thermore, it has been shown that IB–NF-B complexes 
undergo cytoplasmic to nuclear shuttling in resting cells, 
whereas IB–NF-B complexes commonly stay in the cyto-
plasm (Tran et al., 1997; Huang and Miyamoto, 2001; Malek 
et al., 2001; Ghosh and Karin, 2002). A hypophosphorylated 
form of IB has been shown to reside in the nucleus of certain 
cell types upon stimulation. Nuclear IB is capable of forming 
a complex with DNA–NF-B dimers, but is unable to dislocate 
NF-B from the DNA, thereby prolonging NF-B activity 
(Suyang et al., 1996; DeLuca et al., 1999).
Accumulating evidence points to a broader nuclear func-
tion of the IB protein family (Bates and Miyamoto, 2004). 
Certain  IB  protein  family  members  associate  specifically 
with definite NF-B proteins, acting as transcription coacti-
vators at distinct genes. Thus, IB cooperates with RelA/
p65 in the regulation of the Notch-target gene hes1 after 
stimulation with TNF (Aguilera et al., 2004). IB associates 
specifically with p50 to the NF-B–binding site of the IL-6 
promoter (Yamamoto et al., 2004).
Less is known regarding the function of IB in vivo. To 
analyze  the  physiological  function  of  IB,  we  generated 
IB-deficient (IB/) mice. We demonstrate that IB/ 
mice are highly resistant to LPS-induced septic shock. LPS 
resistance is caused by impaired cytokine expression in IB/ 
mice. Using the IL-1 gene as a model of IB regulated 
NF-B target genes, we demonstrate that IB is essential for 
IL-1 production upon LPS. In addition, we show that the 
transcription of IL-1 depends on a positively acting p65–
c-Rel–IB complex.
RESULTS
Generation and immunological phenotype of IB/ mice
To elucidate the physiological role of IB, we generated 
IB/ mice using targeted gene disruption (as described in 
the Materials and methods section; Fig. 1 A). Exons 4 and 5 
of the IB gene, which code for the ankyrin repeats 4–6 
that are essential for the function of IB proteins and the 
binding to NF-B, were deleted (Inoue et al., 1992). Southern 
blot analysis of the genomic tail DNA of F2 mice demonstrated 
a complete deletion of the IB alleles (Fig. 1 B). Western 
blot analysis of whole spleen extracts indicated that IB 
expression was completely abolished in IB/ mice with 
no change in the expression of IB and IB (Fig. 1 C).
IB/ mice born with the expected Mendelian fre-
quency were viable and showed no distinct abnormalities 
in appearance. Flow cytometric analysis of isolated spleen 
cells from WT and IB/ mice demonstrated an increase 
in marginal zone B cells and a reduction of naive B cells 
(Fig. S1, A and B). Furthermore, increased memory T cell 
population in the spleen of IB/ mice was observed 
(Fig. S1 C) and analyses of BM exhibited an increase in 
BM-derived  macrophages  (BMDMs)  in  IB/  mice 
(Fig. S1 D).JEM VOL. 207, November 22, 2010 
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to LPS, we stimulated cells with TNF and 
other TLR ligands. The IB deficiency 
did  not  influence  IL-1  secretion  in-
duced by TNF, CpgA (TLR9 agonist), 
and CpgB (TLR9 agonist) in BMDMs 
(Fig. S2). Although IL-1 secretion was 
decreased in polyI:C (TLR3 agonist) and 
Pam3CysSK4  (TLR2  agonist)-treated 
BMDMs, this reduction was not statisti-
cally significant (Fig. S2). Collectively, 
these data argue that IB functions spe-
cifically in certain NF-B pathways.
Influence of IB small  
interfering RNA (siRNA) on IL-1 
transcriptional regulation
To dissect the function of IB in IL-1 
expression in further detail in vitro, we 
used  RNA  interference  in  the  macro-
phage cell line RAW264.7. Transfection 
of RAW264.7 macrophages with an IB-specific siRNA 
led to a pronounced reduction in the IB protein expres-
sion (Fig. 5 A). To test the IB function in IL-1 secretion, 
we stimulated IB siRNA-transfected RAW264.7 macro-
phages with LPS and measured IL-1 secretion over time 
(Fig. 5 B). Whereas control siRNA-transfected RAW264.7 
cells secreted IL-1, IL-1 production was impaired in IB 
siRNA-transfected cells (Fig. 5 B). In contrast, no change in 
LPS-induced secretion of other NF-B target genes MIP-2 
and  TNF were observed in IB siRNA-transfected RAW264.7 
macrophages, demonstrating specific interaction of IB and 
IL-1 transcription (Fig. 5 B; Kim et al., 2003).
To further elucidate IB-dependent regulation of the 
IL-1 promoter, we transfected several IL-1 reporter gene 
Binding of LPS to Toll-like receptor 4 (TLR4) activates 
NF-B through IKK in a MyD88-dependent manner. To test 
for altered signaling kinetics and DNA binding in IB/ 
BMDMs, we performed electrophoretic mobility shift assays 
(EMSAs). Once normalized to Oct1 DNA binding, LPS- 
induced NF-B signaling kinetics were indistinguishable 
(Fig. 4 C). No differences in the protein expression level of 
NF-B1 or NF-B2 were evident in BMDMs of IB/ 
mice (unpublished data). RelA/p65 expression was decreased 
and c-Rel expression increased in BMDMs of IB/ mice 
(Fig. 4 D). IB was phosphorylated and both, IB and IB, 
were degraded with the same kinetics upon LPS treatment in 
WT and IB/ mice (Fig. 4 D). To determine whether the 
defect of IB/ macrophages that produce IL-1 was specific 
Figure 1.  Disruption of the IB gene.  
(A) Schematic structure of WT IB locus.  
Ankyrin repeats of IB encoded by exons 2–5 are 
indicated. Furthermore, the targeting vector, the 
targeted IB locus, the floxed IB locus, and 
the IB knock-out locus, generated by Cre re-
combination-mediated deletion of exons 4 and 5 
are shown. Solid boxes represent exons, and lines 
represent introns. Neo, loxP-flanked PGK-neomycin 
cassette; HSV-tk, HSV-thymidine kinase gene; B, 
BamHI site. The length of BamHI-generated  
restriction fragments detected by Southern blot-
ting with a 5 flanking probe is indicated. Loca-
tion of the 5 flanking probe in exon 2 is shown. 
(B) Southern blot analysis of genomic DNA from 
targeted ES cells (+/3loxP), WT (+/+) mice, 
IB+/, and IB/ F2 mice. (C) Immunoblot 
analysis of IB, IB, and IB in whole-cell 
extract of WT and IB/ (ko) spleens. The 
membrane was stripped and probed for -actin 
to ensure equal protein loading.2624 IB and septic shock | Scheibel et al.
ChIP analysis using RAW264.7 macrophages demonstrated 
recruitment of IB to the B site of IL-1 promoter upon 
stimulation with LPS (Fig. 6 A). In contrast, IB was not re-
cruited to NF-B–binding site in the MIP-2 gene promoter, 
suggesting specific regulation of the IL-1 promoter by IB 
(Widmer et al., 1993). To characterize the activation complex 
in more detail, we investigated p65, p50, p52, and c-Rel bind-
ing. In addition to IB, we found recruitment of the p65– 
c-Rel complex to the IL-1 promoter after LPS stimulation 
in RAW264.7 macrophages, suggesting that a p65–c-Rel dimer, 
assembled by IB, induces IL-1 transcription after LPS 
treatment. In contrast, a classical NF-B (p50/p65) dimer was 
recruited to the MIP-2 promoter upon LPS treatment and no 
binding of IB was observed, demonstrating specificity for 
the IL-1 promoter (Fig. 6 A). Functionality of c-Rel for 
LPS-induced IL-1 transcription was also demonstrated using 
RNA interference in RAW264.7 macrophages (Fig. S3).   
To further demonstrate the influence of IB for dimer forma-
tion at the IL-1 promoter at the genetic level, we used ChIP 
assays in IB/ BMDMs. Binding of IB to the IL-1 
promoter upon LPS treatment was confirmed in BMDMs 
(Fig. 6 B). Whereas, c-Rel binds to the IL-1 promoter in WT 
macrophages,  reduced  binding  was  observed  in  IB/ 
BMDMs (Fig. 6 B). A significant lower binding of RNA 
polymerase  II  to  the  IL-1  promoter  indicated  decreased 
transcriptional activity in IB/ cells after LPS treatment 
(Fig. 6 B). On the other hand, complex formation and re-
cruitment of RNA polymerase II after LPS treatment was not 
changed at the MIP-2 promoter gene in IB/ BMDMs, 
confirming specificity for the IL-1 promoter (Fig. 6 B). 
Consistent with a nuclear function of IB, we observed nuclear 
accumulation of IB in LPS-treated BMDMs (Fig. S4). Pre-
vious studies demonstrated the interaction of IB with c-Rel–
p65 complexes in stimulated WEHI 231 cells in the nucleus 
(Phillips and Ghosh, 1997). To investigate direct interaction of 
the  IB–p65–c-Rel  complex  with  DNA,  we  performed 
pulldown assays in Raw264.7 macrophages using biotinylated 
B oligonucleotides corresponding to the proximal B binding 
site of the IL-1 promoter. In nuclear extracts an IB–p65–
c-Rel trimer was found bound to the proximal B binding 
site of the IL-1 promoter after LPS treatment (Fig. 6 C).   
constructs into RAW264.7 macrophages (Fig. 5 C). The 518 
bp IL-1 reporter gene, harboring two functional B binding 
sites, showed an eightfold increase activity 8 h after stimula-
tion with LPS in RAW264.7 macrophages (Cogswell et al., 
1994;  Fig.  5  D).  Deleting  the  distal  NF-B–binding  site 
(399IL-1B) did not impair inducibility, whereas mutation 
or deletion of the proximal B site significantly decreased 
LPS induction. These data suggest that the proximal B 
site contributes to LPS-induction of the IL-1 promoter in 
RAW264.7 macrophages. However, we cannot completely 
exclude the contribution of the distal B site.
To investigate whether IB is essential for LPS-mediated 
induction of the IL-1 promoter, RAW267.6 macrophages 
were cotransfected with IB siRNA and IL-1 reporter 
gene constructs. As shown in Fig. 5 E, knockdown of IB 
clearly reduced IL-1 promoter induction after LPS stimula-
tion, again pointing to a coactivator function of IB toward 
IL-1 transcription.
Recruitment of IB to the IL-1 promoter in complex 
with NF-B p65–c-Rel
To test whether IB directly binds to the IL-1 promoter, 
we performed chromatin immunoprecipitation (ChIP) assays. 
Figure 2.  Survival of IB/ mice after high-dose LPS challenge. 
Survival curves of IB/, IB+/, and WT mice after the injection of 
LPS (30 mg/kg). Kaplan-Meier analysis demonstrated a significant differ-
ence in survival between IB/ and WT (log-rank test IB/ versus 
WT; P < 0.0001). Data are from three separate experiments and the num-
ber of mice in each group is indicated.
Figure 3.  Deficiency in IB reduces LPS- 
triggered production of sepsis inducing cytokines.  
(A) Serum levels of IL-1, TNF, and IL-6 in IB/ 
and control mice after LPS injection (30 mg/kg). TNF, 
IL-1, and IL-6 were measured in serum collected 
from tail vain 0, 1, 2, and 6 h after injection of LPS 
(Student’s t test; *, P < 0.001 versus controls). (B) Liver 
IL-1, TNF, and IL-6 mRNA expression levels after LPS 
challenge (30 mg/kg). At the indicated time points 
after LPS injection (30 mg/kg), total RNA from whole 
livers were prepared and mRNA levels were quantified 
using real-time PCR analysis (Student’s t test;  
*, P < 0.05 versus controls). For each time point,  
four animals per strain were examined in two inde-
pendent experiments.JEM VOL. 207, November 22, 2010 
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subsequent lethal organ failure. Thus, the expression of proin-
flammatory cytokines like IL-1, TNF, and IL-6 needs to be 
tightly regulated during an inflammatory response. We now 
demonstrate that IB is a critical regulator of LPS-induced 
septic shock. IB deficiency confers LPS resistance in vivo, 
which is caused by the impaired secretion of the proinflam-
matory cytokines IL-1, TNF, and IL-6. In BMDM, IL-1 
was determined as a specific molecular IB target, whereas 
the activation of the TNF and IL-6 genes remained unaf-
fected after LPS treatment in this particular cellular model. 
Because IL-1/ mice are not protected from high-dose, 
LPS-induced septic shock, other IB targets have to con-
tribute to the observed LPS resistance (Fantuzzi et al., 1996). 
The importance of the IL-1 system for high-dose, LPS- 
induced septic shock is reflected by the LPS resistance of the 
IL-1 converting enzyme–deficient mice, known to have 
neither detectable serum levels of IL-1 nor IL-1 upon LPS 
challenge (Li et al., 1995). Interestingly, in microarray analysis 
of LPS-treated BMDMs, IL-1 induction after LPS stimula-
tion was impaired in IB/ BMDMs (Table S1). However, 
Glaccum et al. (1997) reported that IL-1R/ mice, which 
are refractory to both IL-1 and IL-1 signaling, are not re-
sistant to LPS-induced septic shock, indicating that additional 
genes must contribute to the resistance in IB/ mice to 
LPS-induced lethality. The observation that several genes with 
important functions in innate immunity such as the chemokine 
(C-X-C motif) ligand 1 (Cxcl1), suppressor of cytokine sig-
naling 3 (Socs3), interleukin 12p40 (Il12b) or others induced 
by LPS in BMDMs in an IB-dependent manner, points to 
the possibility that a complex IB-controlled genetic net-
work mediates the LPS resistance observed in IB/ mice. 
No binding of c-Rel was detected in unstimulated cells, indi-
cating  that  LPS-signaling  induces  molecular  changes,  like 
p65–c-Rel dimer formation or conformational changes of   
c-Rel, which are needed to detect c-Rel binding to the B 
oligonucleotide in the assay used. Altogether, these data sug-
gest that IB is recruited to the IL-1 promoter after LPS 
treatment and is needed for NF-B complex formation and 
transcriptional activation.
DISCUSSION
Several reports of mice with targeted disruptions of IB family 
members demonstrated that the different proteins play distinct 
biological roles. In contrast to IB, much less is known re-
garding to the in vivo function of IB. In this study, we ana-
lyzed IB/ mice and demonstrate a novel function of 
IB in the whole organism. IB/ mice share none of 
the hallmarks compared with IB/ mice (Beg et al., 1995; 
Klement  et  al.,  1996).  Similar  to  IB/  mice,  IB/ 
mice survive to adulthood and show no overt abnormalities 
(Mémet et al., 1999). However, our results demonstrate that 
IB  is  essential  in  regulating  innate  immunity  in  a  LPS 
model of septic shock.
Bacterial infection can induce a systemic response charac-
terized by multiple organ failure and high mortality rate. LPS, 
a major integral structural component of the outer mem-
brane of Gram-negative bacteria, is a potent initiator of in-
flammation and endotoxin shock. LPS activates macrophages 
to produce cytokines, such as IL-1, TNF, and IL-6, which 
serve  as  critical  mediators  of  septic  shock  (Morrison  and 
Ryan, 1987). Excessive production of these cytokines leads to 
capillary leakage, vascular hemorrhage, tissue destruction, and 
Figure 4.  Knockout of IB exhibit  
reduced IL-1 expression in macrophages 
(BMDMs). (A) WT and IB/ BMDM (three 
animals for each group) were stimulated with 
LPS (1 µg/ml) as indicated. Total RNA was pre-
pared and IL-1, TNF, and IL-6 mRNA levels 
were quantified using real-time PCR analysis 
(left; Student’s t test; *, P < 0.01 versus con-
trol). IL-1, IL-6, and TNF cytokine secretion in 
response to LPS was determined by ELISA 
(right; Student’s t test; *, P < 0.01 versus con-
trol). Results are shown as the mean of two 
independent experiments. (B) BMDMs from WT 
and IB/ mice were stimulated with LPS  
(1 µg/ml) for indicated time points or were left 
as an untreated control. Western blot detects 
IB and pro–IL-1 expression. Similar results 
were obtained from two additional experi-
ments. -actin was used as loading control.  
(C) EMSA using a radiolabeled probe contain-
ing an NF-B–binding site. BMDMs were LPS-
treated (100 ng/ml) as indicated and nuclear 
extracts were analyzed by EMSA. An Oct- 
consensus oligonucleotide was used to control equal protein input. Three independent experiments revealed similar results. (D) BMDMs isolated from WT 
and IB/ mice were stimulated with LPS (100 ng/ml) and analyzed by Western blot. Expression levels of indicated NF-B proteins and IB members 
were determined at the indicated time points. One out of three independent experiments is shown.2626 IB and septic shock | Scheibel et al.
(Beutler, 2004; Beutler, 2009). The mechanisms by which LPS 
induces septic shock is related to its ability to activate NF-B. 
For example, the highly LPS susceptible secretory leukopro-
tease inhibitor–deficient mice are characterized by an increased 
NF-B signaling magnitude, and the LPS-resistant poly 
ADP-ribose polymerase-1–deficient mice demonstrate a dis-
tinct impaired NF-B activation (Oliver et al., 1999; Nakamura 
et al., 2003). IB is thought to control late-phase NF-B 
activation (Hoffmann et al., 2002). This IB activity was not 
observed in LPS-stimulated BMDMs because LPS stimula-
tion results in similar NF-B activation kinetics in WT and 
IB/ cells. Because IB is present in IB/ cells and 
degraded with the same kinetics as in WT BMDMs, IB may 
compensate for the IB loss.
We detected a gene-specific activator function of IB 
during the early LPS-induced NF-B response. As a model of 
IB-dependent transcriptional regulation, we focused onto 
the control of the IL-1 promoter because induction of 
this gene by LPS mostly depends on IB, revealing a ten 
fold decreased inducibility in WT compared with IB/ 
BMDMs (Table S1). We observed a direct recruitment of 
IB to the B-binding site of the IL-1 promoter in com-
plex with p65/c-Rel. Interestingly, in BMDMs of IB/ 
mice the lack of IB binding to the IL-1 promoter leads 
to the loss of c-Rel recruitment as well as reduced binding 
of RNA polymerase II, indicating reduced transcriptional 
Analysis of the IB-dependent genes (Table S1) using 
Genomatix Pathway System software revealed a significant 
enrichment of genes controlled by the canonical IL-1–
IKK–NF-B signaling pathway (P < 0.01) and MyD88 re-
sponse genes (P < 0.001), arguing that a subset of NF-B– and 
MyD88-regulated genes is regulated by IB (unpublished 
data). Furthermore, we observed a discrepancy between LPS-
induced secretion of the proinflammatory cytokines in the 
BMDM model and LPS-induced cytokine expression mea-
sured in liver and serum. In BMDMs, only IL-1 secretion 
was impaired because of IB deficiency, whereas the LPS-
induced expression of IL-1, TNF, and IL-6 was dependent 
on IB in vivo. The liver is important for the initiation of 
defense mechanisms and the initiation of multiorgan failure 
during sepsis. LPS has been shown to activate hepatic Kupffer 
cells to synthesize and secrete inflammatory cytokines such as 
IL-1, TNF, and IL-6 (Koo et al., 1999). Therefore, we cannot 
exclude that a different set of genes controlled by IB in re-
sponse to LPS in Kupfer cells, including IL-1, TNF, and IL-6, 
are responsible for the LPS-resistance observed in IB/ 
mice in vivo. Thus, tissue and cell type specificities have to be 
considered in this context.
LPS is sensed by TLR4. Signaling via TLR4 activates a 
TRIF-dependent pathway of the induction of IFN- and 
IFN-inducible genes in a MyD88-dependent pathway lead-
ing to activation of a NF-B–dependent genetic program 
Figure 5.  IB knock down results  
a significant reduction in IL-1 cytokine 
expression and secretion. (A) Silencing of 
IB expression in RAW264.7 macrophages 
using siRNA. RAW264.7 macrophages were 
transfected with control or IB-specific 
siRNAs or were left as an untransfected con-
trol. After 48 h, Western blot detected IB 
expression. -actin was used as loading con-
trol. (B) Measurement of IL-1, MIP-2, and 
TNF cytokine secretion in control and IB 
siRNA-transfected RAW264.7 cells. 48 h after 
transfection, cells were treated with LPS  
(100 ng/ml) and cytokine secretion was mea-
sured by ELISA. Data were obtained from three 
independent experiments performed in tripli-
cate, and the results are presented as mean 
and SEM. (C) Schematic maps of different 
luciferase reporter genes containing IL-1 
promoter luciferase reporter gene constructs. 
Three different luc-constructs encoding IL-1 
promoter sequence starting from 518, 399, 
and 133, respectively, were used in transient transfection assays in RAW264.7 macrophages. The IL-1–Luc construct IL-1B-518 includes two  
functional B sites, whereas the IL-1B-399 contains only one functional B site. No B sites are present in the 133 IL-1–Luc construct. In the mut-
399-IL1B-luc construct, a mutation was introduced into the B site by site-directed mutagenesis, as indicated. (D) RAW264.7 macrophages were trans-
fected with 1 µg of the indicated IL-1 promoter luciferase reporter gene constructs. 48 h after the transfection, cells were stimulated with LPS  
(100 ng/ml) for 8 h and luciferase activity was determined. Data were obtained from three independent experiments performed in triplicate, and the  
results are presented as mean and SEM. (E) RAW264.7 macrophages were cotransfected using 1 µg of the indicated IL-1 promoter luciferase reporter 
gene constructs, a control siRNA, an IB-specific siRNA, or they were left as an untransfected control. 48 h after the transfection, cells were stimulated 
with LPS (100 ng/ml) for 8 h and luciferase activity was determined. Data were obtained from three independent experiments performed in triplicate, and 
the results are presented as mean and SEM.JEM VOL. 207, November 22, 2010 
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specificity of IB toward certain NF-B– and MyD88- 
regulated promoters and recruitment of a p65/c-Rel dimer to 
the IL-1 promoter, we propose that the IB proteins function 
to confer selectivity in NF-B dimer usage, and therefore in 
signaling specificity. In addition to IB and IB, IB was 
shown to repress the hes1 promoter by direct binding (Aguilera 
et al., 2004). Furthermore, it was demonstrated that IB inter-
acts with corepressors, like SMRT and N-Cor and different his-
tone deacetylases (Aguilera et al., 2004). Whether IB interacts 
with the epigenetic machinery is unknown in the moment and 
awaits further experiments.
Together, we now provide genetic evidence that IB is 
essential for resistance toward LPS induced septic-shock. At the 
molecular level, IB binds to a subset of NF-B–dependent 
promoters and activates a subset of LPS-induced genes, like 
the IL-1 gene. This establishes IB as an essential coactivator 
for gene transcription in vivo.
MATERIALS AND METHODS
Targeted disruption of the IB gene. The 8.2-kb genomic clone con-
taining exons 3–6 of IB was isolated from a genomic 129/Sv -DASHII-
phage library. In the targeting vector, a loxP-flanked PGK-neomycin (neo)-cassette 
was introduced into intron 3. An additional loxP site was cloned into the 
AvrII site in intron 5. Thereby the BamHI sites in intron 3 and intron 5 were 
destroyed. The HSV-thymidine kinase gene was inserted 3.5 kb downstream of 
the neo-cassette. Embryonic stem cells (line E 14.1) were electroporated with 
the linearized vector (10 µg) and selected with G418 (300 µg/ml; Biochrom) 
and gancyclovir (2 µM; Sigma-Aldrich). Resistent clones were screened for 
homologous recombination by PCR. Positive clones were verified by South-
ern blot analysis using an external 5 flanking probe (exon 2) and a neo probe. 
Correctly targeted ES cells were electroporated with pi-Cre-Plasmid (10 µg), 
to remove the neo-cassette, and selected with neomycin. Neomycin-sensitive 
activation. Therefore, the remaining p65/RelA homodimers 
are not sufficient to activate IL-1 transcription, suggesting 
that IB is indispensable in formation of a transcriptional ac-
tive p65–c-Rel complex at the IL-1 promoter. This is in line 
with recent observations, demonstrating that each NF-B 
dimer supports a different amount of transcriptional activation 
at a specific gene promoter and that the IL-1 gene-promoter 
is most responsive to p65/RelA and c-Rel in vitro (Algarté et al., 
1999; Hiscott et al., 1993; Lin et al., 1995; Saccani et al., 2003).
As previously characterized, a stable complex of IB and 
NF-B p65/c-Rel can be found in the nucleus of WEHI 231 
cells (Phillips and Ghosh, 1997). Using an oligonucleotide with 
specific B-binding sequence, we can also identify a NF-B 
p65–c-Rel–IB complex in the nucleus of RAW264.7 
macrophages after treatment with LPS, suggesting that IB 
exists in the nucleus of macrophages, as found constitutively in 
WEHI 231 cells and LPS-stimulated 70/Z3 cells (Phillips and 
Ghosh, 1997; Suyang et al., 1996). Consistently, nuclear trans-
location of IB was observed in LPS-stimulated BMDMs. 
Because IB is clearly needed to recruit c-Rel to the IL-1 
promoter, we suggest a more active role for IB in gene 
transcription than a sole chaperone function.
In addition to the inhibitory function of the IB protein 
family in resting cells, promoter-specific functions are becoming 
more evident. LPS signaling induces expression of IB in 
macrophages, which is important for the induction of a subset 
of LPS-induced genes, like IL-6, by forming a promoter-bound 
p50–p65–IB complex. Interestingly, LPS induction of IL-6 in 
macrophages was not shown to be IB dependent (Yamamoto 
et al., 2004). Together with our data, which demonstrates   
Figure 6.  Recruitment of IB to the IL-1  
promoter in complex with NF-B p65/c-Rel. (A) ChIP 
in RAW264.7 macrophages. RAW264.7 macrophages 
were stimulated for 2 h with LPS (100 ng/ml). Chromatin 
was immunoprecipitated with IB-, RelA/p65-,  
NF-B1/p50–, NF-B2/p52–, c-Rel-, and RNA- 
polymerase II–specific antibodies or IgG as a negative 
control. Precipitated DNA or 10% of the chromatin input 
was amplified with gene-specific primers for IL-1 or 
MIP-2 promoters. Three independent experiments re-
vealed similar results. (B) ChIP in BMDMs. After stimula-
tion with LPS (100 ng/ml) for 1 h, chromatin was 
immunoprecipitated with IB-, RelA/p65-, NF-B1/
p50–, NF-B2/p52–, c-Rel-, and RNA-polymerase II–
specific antibodies or IgG as a negative control. Precipi-
tated DNA or 10% of the chromatin input was amplified 
with gene-specific primers for IL-1 or MIP-2 promoters. 
Three independent experiments revealed similar results. 
(C) Biotin-streptavidin pulldown assay with a B oligo-
nucleotide, corresponding to the proximal B site of the 
IL-1 promoter. RAW264.7 macrophages were stimu-
lated with LPS (100 ng/ml) for 2 h. Nuclear and cytoplas-
mic extracts were incubated with the B oligonucleotide 
and pulled down with streptavidin-agarose. Western blot 
detected RelA/p65, c-Rel, and IB. One out of three 
independent experiments is shown.2628 IB and septic shock | Scheibel et al.
Southern and Western blot analysis. 10 µg of genomic tail DNA was di-
gested with BamH I, yielding 4.8 and 3.1 kb fragments for IB/ and IB 
WT alleles, respectively. DNA was separated on agarose gels and transferred to 
nitrocellulose membrane (GeneScreen Plus; DuPont). Hybridization was per-
formed using hybridization buffer (1 M NaCl, 100 mg/ml dextran sulfate, 1% 
SDS, and 50 µg/ml salmon sperm DNA) and a Rediprime random primer la-
beling kit (GE Healthcare) with P32 -dCTP–labeled probes.
Whole-cell lysates were prepared and Western blots and immunoprecip-
itations were done as previously described (Fritsche et al., 2009; Schneider et 
al., 2006, 2010). The following antibodies were used: IB-, p65, p50, p52,   
c-Rel,  IB-,  phospho-IB,  IB-  (Santa  Cruz  Biotechnology,  Inc.),   
IL-1 (R&D Systems), and -actin (Sigma-Aldrich). Proteins were detected 
by Odyssey Infrared Imaging System (Licor).
Cell isolation and culture. For generating BMDMs, mice were killed by cervi-
cal dislocation under ether anesthesia and BM was flushed from humerus, femur, 
and tibia of 6–8 mice. Cells were collected and washed as previously described 
(Ohashi et al., 2000). Pluznik medium containing RPMI 1640, 5% heat-inacti-
vated horse serum (PAA), 15% FCS (PAA), 15% culture supernatant from M-CSF 
producing L929 cells (DSM ACC), and 1% P/S was used for cell culturing. After 
6 d, the enriched macrophages were used for experiments as indicated.
Flow cytometry. Fluorescence staining of isolated mouse splenocytes was 
performed as described previously (Rad et al., 2006). The following antibodies 
were used: PE-conjugated anti-IgD (SouthernBiotech); biotinylated anti-
CD3  (Caltag  Laboratories);  PE-conjugated  anti-Terr-119,  PE-conjugated 
anti-CD45RB,  PE-conjugated  anti-CD19, APC-conjugated  anti-CD62L, 
FITC-conjugated  anti-CD23,  FITC-conjugated  anti-CD21,  biotinyl-
ated anti-IgM, APC-conjugated anti-CD11b, biotinylated anti-CD3 (BD). 
Streptavidin-PerCP was from BD. Fluorescence was analyzed by using a 
FACSCalibur (BD) flow cytometer and CellQuest software (BD).
Biotin-streptavidin pulldown assay. Assays were performed as previously 
described (Schild et al., 2009; Schneider et al., 2010). Approximately 7 × 107 
RAW264.7 macrophages were used for each time point. Nuclear and cyto-
solic extract were prepared by using nuclear extraction kit (Active Motif) 
according to the manufacturer’s instructions. The following 5 biotin-labeled 
oligonucleotide, corresponding to the positions 261 to 270 of the IL-1 
promoter, was used: 5-ACCCCAGGAAAACCCAATATTT-3.
IL-1 promoter reporter gene assay and mutagenesis. To determine 
IL-1 promoter activity the 518-IL1B-luc, 399-IL1B-luc, and 199-
IL1B-luc  luciferase  reporter  gene  constructs  were  used.  Point  mutations 
within the 399-IL-1B-luc plasmid were generated using the QuikChange 
Site-Directed Mutagenesis kit (Stratagene) in conjugation with the following 
oligonucleotides: 5-CATTCTTCTAACGTGTTGGAATCCACTATTAT-
GTGGAC-3  and  5-GTCCACATTAAACTGGATTCCAACACGTTAG-
AAGAATC-3.  Mutated  residues  are  shown  in  Fig.  5  C.  Mutations  were 
confirmed by sequencing. 1 µg of each reporter gene constructs was transfected 
using Oligofectamine (Invitrogen). Luciferase activity was normalized to protein 
concentration and analyzed as previously described (Reichert et al., 2007).
Assay with siRNA specific to IB and c-Rel. RAW264.7 macro-
phages were transfected with siRNA duplex (Ambion) specific for mouse 
IB or with scramble duplex in a concentration of 200 nM with Oligo-
fectamine (Invitrogen) according to the manufacturer’s instructions. The fol-
lowing siRNAs were used: IB, 5-GACUGGAGGCUACAACUAG-3; 
c-Rel,  5-AUAGCAUGUUGACAUCAGACAUACU-3;  control  siRNA, 
5-CAGUCGCGUUUGCGACUGG-3.
EMSA.  EMSAs  were  performed  as  previously  described  (Arkan   
et al., 2001) using NF-B (5-AGTTGAGGGGACTTTCCCAGGC-3 
and 3-TCAACTCCCCTGAAAGGGTCCG-5) and Oct-1 (5-TGTC-
GAATGCAAATCACTAGAA-3 and 3-ACAGCTTACGTTTAGTGA-
TCTT-5) oligonucleotides.
clones were analyzed by Southern blot and PCR analyses to validate the correct 
deletion of the neo-cassette. These clones were aggregated to C57BL/6 mor-
ulae, and resulting chimeric mice were crossed with Deleter-Cre-mice to generate 
IB knockout mice (Schwenk et al., 1995). Disruption of the IB gene 
was verified by Southern blot und PCR analyses of tail DNA. Homozygous 
offspring were obtained at the predicted frequency by interbreeding hetero-
zygous mice. The null phenotype created by mutation of the IB gene was 
confirmed by  Western blot analysis of spleen extracts. For LPS injection, IB/ 
mice were backcrossed at least 7 times to the C57BL/6 background.
Reagents. CpG 1826 B-type, CpG 2216 A-type, PAM3CSK4, and PolyIC 
were purchased from Sigma-Aldrich.
Systemic challenge of WT and IB/ mice. WT C57BL/6 (litter-
mate controls or purchased from Charles River Laboratories), IB+/ lit-
ters, and IB/ mice were injected i.p. with LPS 30 mg/kg (L-2630, strain 
0111:B4; Sigma-Aldrich). Mice were monitored over 72 h for signs of sepsis 
and lethality. Blood was taken from the tail vein 0, 1, 2, and 6 h after LPS 
injection to investigate serum levels of IL-1, TNF, and IL-6 using ELISA. 
All animal studies were conducted in compliance with European guidelines 
for the care and use of laboratory animals and were approved by the local 
authorities (Regierung von Oberbayern).
Immunocytochemistry. For immunodetection of IB and RelA/p65 in 
WT and IB/ LPS or untreated BMDMs, cells were fixed in 4% formal-
dehyde  (Sigma-Aldrich),  permeabilized  with  0.3% Triton-X  (Sigma- 
Aldrich), and stained with IB- and RelA/p65-specific primary antibodies 
(Santa Cruz Biotechnology, Inc.), followed by a FITC-labeled secondary anti-
body (Invitrogen). Cells were then counterstained with DAPI (Vector 
Laboratories) to identify nuclei and subjected to fluorescence microscopy 
(Axiovert 200 M; Carl Zeiss, Inc.). Emitted fluorescence was collected on   
a color charge-coupled device camera system (AxioCam MRc; Carl Zeiss, 
Inc.). High-resolution images were captured and analyzed using AxioVision 
4.3 software (Carl Zeiss, Inc.).
ChIP. ChIP assays were performed as previously described (Fritsche et al., 
2009; Schneider et al., 2006, 2010). An equal amount of chromatin (50–100 µg) 
was used for each precipitation. The following antibodies were used: IB-, 
RelA/p65, c-Rel, p50, p52, RNA-Polymerase II, and control IgG, all from Santa 
Cruz Biotechnology. One twentieth of the precipitated chromatin was used 
for each PCR reaction. To ensure linearity, 28 to 38 cycles were performed, 
and one representative result is shown. Sequences of the promoter specific 
primers are as follows: IL-1 promoter (347/151): sense, 5-TCCC-
TGGAAATCAAGGGGTGG-3,  antisense  5-TCTGGGTGTGCATCT-
ACGTGCC-3; MIP-2 promoter (-433/-138): sense 5-CAACAGTGTACT-
TACGCAGACG-3, antisense 5-CTAGCTGCCTGCCTCATTCTAC-3.
Quantitative real-time RT-PCR. Total RNA was isolated from liver, 
BMDMs, or RAW264.7 macrophages was isolated using the RNeasy kit 
(Qiagen) following the manufacturer’s instructions. Quantitative mRNA 
analyses were performed as previously described using real-time PCR analy-
sis (TaqMan, PE Applied Biosystems; Schneider et al., 2006; Fritsche et al., 
2009). Sequences of the primers are: IL-1, forward 5-CTCAATG-
GACAGAATATCAACCAACA-3  and  reverse  5-ACAGGACAG-
GTATAGATTCTTTCCTTTG-3;  IL-6,  forward  5-TCGGAGGCT-
TAATTACACATGTTCT-3 and reverse IL-6 R 5-GCATCATCGTT-
GTTCATACAATCA-3;  TNF,  forward  5-ATGAGAAGTTCCCAA-
ATGGCC-3  and  reverse  5-TCCACTTGGTGGTTCGCTACG-3;   
Cyclophilin, forward 5-ATGGTCAACCCCACCGTGT-3 and reverse 
5-TTCTGCTGTCTTTGGAACTTTGTC-3.
Determination of cytokine secretion. Cytokine levels in blood sera and 
culture supernatants of IL-1, TNF, and IL-6 were determined using com-
mercially available ELISA kits, according to the manufacturer’s instructions 
(R&D Systems).JEM VOL. 207, November 22, 2010 
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